Download PDF
Thromb Haemost 1998; 79(02): 450-451
DOI: 10.1055/s-0037-1615014
Scientific and Standardization Committee Communication
Schattauer GmbH

The Mutation C677 → T in the Methylene Tetrahydrofolate Reductase Gene and Stroke

Karl H. Reuner
1   From the Institute for Medical Laboratory Diagnostics and Department of Neurology, Klinikum Karlsruhe, Germany
,
Andreas Ruf
1   From the Institute for Medical Laboratory Diagnostics and Department of Neurology, Klinikum Karlsruhe, Germany
,
Michael Kaps
1   From the Institute for Medical Laboratory Diagnostics and Department of Neurology, Klinikum Karlsruhe, Germany
,
Karl F. Druschky
1   From the Institute for Medical Laboratory Diagnostics and Department of Neurology, Klinikum Karlsruhe, Germany
,
Heinrich Patscheke
1   From the Institute for Medical Laboratory Diagnostics and Department of Neurology, Klinikum Karlsruhe, Germany
› Author Affiliations
Further Information

Publication History

Received 02 July 1997

Accepted after resubmission 22 September 1997

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Nehler MR, Taylor LM, Porter JM. Homocysteinemia as a Risk Factor for Atherosclerosis: A Review. Cardiovasc Pathol 1998; 6: 1-9.
    PubMedGoogle Scholar
  • 2 Mudd SH, Levy HL, Skovby B. Disorders of transsulfuration. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CT, Beaudet AL, Sly WS, Valle D. eds. 7th edn. McGraw-Hill; New York: 1995. pp 1279-327.
    Google Scholar
  • 3 Rozen R. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inher Metab Dis 1996; 19: 589-94.
    CrossrefPubMedGoogle Scholar
  • 4 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boerst GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 1995; 10: 111-3.
    CrossrefPubMedGoogle Scholar
  • 5 Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Human Gen 1996; 58: 35-41.
    PubMedGoogle Scholar
  • 6 Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H, Kinoshita M. Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis 1996; 121: 293-4.
    CrossrefPubMedGoogle Scholar
  • 7 Grosso LE, Buscetti D, Eby CS. Frequency of the thermal labile mutation of methylenetetrahydrofolate reductase in patients with venous thrombosis. FASEB J 1998; 11: 1816.
    PubMedGoogle Scholar
  • 8 Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677 → Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1998; 77: 818-21.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation 1996; 94: 1812-4.
    CrossrefPubMedGoogle Scholar
  • 10 Wilcken DEL, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol 1996; 16: 878-82.
    CrossrefPubMedGoogle Scholar
  • 11 Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor LM, Press RD. Common mutation in methylenetetrahydrofolate reductase. Circulation 1996; 94: 3074-8.
    CrossrefPubMedGoogle Scholar
  • 12 Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med 1996; 89: 437-44.
    CrossrefPubMedGoogle Scholar
  • 13 Brugada R, Marian AJ. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Atherosclerosis 1998; 128: 107-12.
    PubMedGoogle Scholar
  • 14 Van Bockxmeer FM, Mamotte CDS, Vasikaran SD, Taylor RR. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 1998; 95: 21-3.
    PubMedGoogle Scholar
  • 15 Brulhart MC, Dussoix P, Ruiz J, Passa P, Froguel PH, James RW. The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients. Am J Hum Genet 1998; 60: 228-9.
    PubMedGoogle Scholar
  • 16 Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS, Genest J, Rozen R. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 17: 569-73.
    PubMedGoogle Scholar
  • 17 Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9.
    CrossrefPubMedGoogle Scholar
  • 18 Reuner KH, Litfin F, Patscheke H. Discrimination between normal wild-type and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma. Eur J Clin Chem Clin Biochem 1998; 35: 41-5.
    PubMedGoogle Scholar